Figure 1. The RAPID trial of augmentation therapy in severe alpha-1 antitrypsin deficiency.

Intravenous augmentation therapy slowed the loss of lung density on chest CT scans over four years: ( A) all subjects and ( B) subjects completing the open-label extension study. Reprinted from 5, with permission from Elsevier.